ArticleAdvanced therapeutics2024

ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm.

Ryo Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.